106 related articles for article (PubMed ID: 22045829)
21. Pattern of glomerular filtration rate abnormalities in type 2 diabetes mellitus in Jos, Nigeria.
Agaba EI; Agaba PA; Puepet FA; Achinge G
Niger Postgrad Med J; 2004 Dec; 11(4):262-4. PubMed ID: 15627153
[TBL] [Abstract][Full Text] [Related]
22. Effects of high dose aleglitazar on renal function in patients with type 2 diabetes.
Herz M; Gaspari F; Perico N; Viberti G; Urbanowska T; Rabbia M; Wieczorek Kirk D
Int J Cardiol; 2011 Sep; 151(2):136-42. PubMed ID: 20837369
[TBL] [Abstract][Full Text] [Related]
23. Models for plasma glucose, HbA1c, and hemoglobin interrelationships in patients with type 2 diabetes following tesaglitazar treatment.
Hamrén B; Björk E; Sunzel M; Karlsson M
Clin Pharmacol Ther; 2008 Aug; 84(2):228-35. PubMed ID: 18388881
[TBL] [Abstract][Full Text] [Related]
24. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Modification of Diet in Renal Disease Study and Cockcroft-Gault equations for sitagliptin dosing.
McFarland MS; Markley BM; Zhang P; Hudson JQ
J Nephrol; 2012; 25(4):515-22. PubMed ID: 21928236
[TBL] [Abstract][Full Text] [Related]
26. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
[TBL] [Abstract][Full Text] [Related]
27. Renal autoregulation is normal in newly diagnosed, normotensive, NIDDM patients.
New JP; Marshall SM; Bilous RW
Diabetologia; 1998 Feb; 41(2):206-11. PubMed ID: 9498655
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of antihypertensive agents on proteinuria and renal function.
Maki DD; Ma JZ; Louis TA; Kasiske BL
Arch Intern Med; 1995 May; 155(10):1073-80. PubMed ID: 7748051
[TBL] [Abstract][Full Text] [Related]
29. Predictors of long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients.
González-Vilchez F; de Prada JA; Castrillo C; Canteli A; Llano MF; Martín-Durán R
J Heart Lung Transplant; 2011 May; 30(5):552-7. PubMed ID: 21212001
[TBL] [Abstract][Full Text] [Related]
30. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.
Nelson RG; Bennett PH; Beck GJ; Tan M; Knowler WC; Mitch WE; Hirschman GH; Myers BD
N Engl J Med; 1996 Nov; 335(22):1636-42. PubMed ID: 8929360
[TBL] [Abstract][Full Text] [Related]
31. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial.
Pijls LT; de Vries H; van Eijk JT; Donker AJ
Eur J Clin Nutr; 2002 Dec; 56(12):1200-7. PubMed ID: 12494305
[TBL] [Abstract][Full Text] [Related]
32. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
Guimarães J; Bastos M; Melo M; Carvalheiro M
Acta Med Port; 2007; 20(2):145-50. PubMed ID: 17868520
[TBL] [Abstract][Full Text] [Related]
33. [Effect of sugar-reducing therapy on renal function in patients with type II diabetes mellitus].
Mazurov VI; Novik AA; Nagibovich OA; Romashevskiĭ BV; Guliaeva IV; Kurganova TA
Klin Med (Mosk); 1998; 76(6):38-41. PubMed ID: 9693499
[TBL] [Abstract][Full Text] [Related]
34. Assessment of renal function in elderly patients.
Fliser D
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):604-8. PubMed ID: 18941354
[TBL] [Abstract][Full Text] [Related]
35. Tesaglitazar: a promising approach in type 2 diabetes.
Cox SL
Drugs Today (Barc); 2006 Mar; 42(3):139-46. PubMed ID: 16628256
[TBL] [Abstract][Full Text] [Related]
36. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
37. Association between rosiglitazone use and decline in renal function in patients with type 2 diabetes mellitus.
Feldman L; Shani M; Efrati S; Beberashvili I; Baevsky T; Weissgarten J; Vinker S
J Nephrol; 2010; 23(3):350-6. PubMed ID: 20155725
[TBL] [Abstract][Full Text] [Related]
38. Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus.
Hong Y; Rohatagi S; Habtemariam B; Walker JR; Schwartz SL; Mager DE
J Clin Pharmacol; 2008 Jun; 48(6):696-707. PubMed ID: 18372428
[TBL] [Abstract][Full Text] [Related]
39. Renal function in noninsulin-dependent diabetes mellitus patients treated with angiotensin-converting enzyme inhibitors and calcium channel blockers.
Nosadini R; Brocco E; Saller A; Cernigoi AM; Abaterusso C; Bortoloso E; Dalla Vestra M; Maioli M; Piarulli F; Fioretto P
J Hypertens Suppl; 1998 Sep; 16(4):S27-32. PubMed ID: 9817189
[TBL] [Abstract][Full Text] [Related]
40. [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].
Hasslacher C; Vogt C; Raupp D; Dreyhaupt J
Dtsch Med Wochenschr; 2007 Nov; 132(47):2500-4. PubMed ID: 18027324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
